Streetbeat News

Stock Prices

AJG

DRI

FERG

LUNR

MU

Wall Street analysts with high accuracy rates have made recent stock picks, including Micron Technology, which is expected to see a 92% upside. The Federal Reserve cut interest rates, boosting major indices. Benzinga's Analyst Ratings API provides insights into top analyst picks.

Portfolio Pulse from Avi Kapoor

September 23, 2024 | 12:17 pm

GMAB

JHX

KEP

NIO

PGHL

RZLV

ZJYL

Several major stocks, including Jin Medical International, Nio, and others, are experiencing declines in Monday's pre-market session. Jin Medical International saw a significant drop after a sharp rise on Friday.

Portfolio Pulse from Avi Kapoor

September 23, 2024 | 12:17 pm

ASMB

Assembly Biosciences announced interim results from a Phase 1a trial for their helicase-primase inhibitor candidate, ABI-5366. The drug was well tolerated and has a half-life of approximately 20 days, supporting potential once-weekly or once-monthly oral dosing.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 12:15 pm

SPY

Federal Reserve's Neel Kashkari stated that the recent 50 basis point rate cut was a significant move to initiate economic processes. He anticipates smaller rate adjustments in the future.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 12:14 pm

MBRX

Moleculin Biotech presented data at IASLC 2024 on Annamycin, demonstrating significant tumor growth inhibition and extended survival in lung cancer models, with 100% non-cardiotoxicity.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 12:13 pm

RLYB

Rallybio Corporation (NASDAQ:RLYB) will present findings at the ASHG 2024 Annual Meeting showing that the risk of fetal and neonatal alloimmune thrombocytopenia (FNAIT) is more prevalent than previously thought across diverse populations.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 12:13 pm

GHSI

Guardion Health Sciences has announced the termination of its President and CEO, Janet Hall, effective October 17. This leadership change could impact the company's strategic direction and investor confidence.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 12:12 pm

APLS

BK

CAVA

CRWD

FDX

FI

JAKK

PYPL

SBGI

WIX

Top Wall Street analysts have updated their price targets and ratings for several companies, including CrowdStrike, JAKKS Pacific, CAVA Group, and others. Notably, CrowdStrike's price target was raised by Keybanc, leading to an 8.1% increase in its stock price.

Portfolio Pulse from Avi Kapoor

September 23, 2024 | 12:12 pm

BDTX

BHVN

VTYX

Black Diamond Therapeutics, Ventyx Biosciences, and Biohaven saw significant stock movements. Black Diamond's shares rose 54% due to positive Phase 2 data for BDTX-1535. Ventyx Biosciences announced a $27M investment from Sanofi, boosting shares by 42%. Biohaven's shares increased 26% after successful study results for Troriluzole.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 12:10 pm

ACTU

Actuate Therapeutics, Inc. has published new research on elraglusib, a GSK-3β inhibitor, highlighting its potential as an immune modulator in treating neuroblastoma. The study suggests elraglusib could activate the immune system in cancers unresponsive to checkpoint inhibitors.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 12:08 pm